{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:05:18Z","timestamp":1790737518174,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Although uncommon, invasive meningococcal disease (IMD) results in death in 5%\u201310% of cases in healthy children and adolescents. This study aimed to examine demographics, clinical presentation, treatment and outcomes of Australian children hospitalized with IMD during the introduction of the meningococcal vaccine program, overall and by serogroup\/disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective, multicenter study was conducted through the Paediatric Active Enhanced Disease Surveillance network across 8 tertiary pediatric hospitals in Australia. Children 0\u201318 years of age with laboratory-confirmed IMD admitted between July 2016 and June 2022 were included. Clinical data were collected using standardized protocols. Logistic, quantile, negative binomial regression and univariate comparisons were used to compare characteristics by serogroup and to investigate factors associated with disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 137 IMD cases included, 56% were male with a median age of 2 years, 37% were Aboriginal\/Torres Strait Islander children and over half resided in socioeconomically disadvantaged areas. Meningococcal serogroup B (MenB) accounted for 55% of cases, followed by MenW (28%) and MenY (4%). The case fatality rate was 3%. Antibiotics were administered within 1 hour of presentation in 17% of cases. At discharge, 29% had ongoing sequelae, including scarring, arthritis, limb deformities or amputation. Most MenB cases were unvaccinated against MenB (93%), and only 1 MenY case had prior quadrivalent polysaccharide vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study highlights the continued burden of MenB disease, particularly among socioeconomically disadvantaged and Aboriginal and Torres Strait Islander children, underscores the importance of earlier recognition and treatment to reduce morbidity and mortality, and emphasizes the need for improving vaccine uptake and vaccine availability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005214","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:00:20Z","timestamp":1773115220000},"page":"816-824","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Invasive Meningococcal Disease in Australian Children 2016\u20132022: A Multicenter, Prospective Surveillance Study of Serogroup Distribution and Clinical Presentation in the Meningococcal Vaccine Era"],"prefix":"10.1097","volume":"45","author":[{"given":"Maya","family":"Wositzky","sequence":"first","affiliation":[{"name":"PathWest Department of Microbiology, Perth, Western Australia, Australia"},{"name":"Departments of Immunology and General Paediatrics, Perth Children\u2019s Hospital, Perth, Western Austalia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Louise","sequence":"additional","affiliation":[{"name":"Women\u2019s and Children\u2019s Research Centre, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"},{"name":"Biostatistics Unit, South Australian Health & Medical Research Institute, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"D\u2019Angelo","sequence":"additional","affiliation":[{"name":"Vaccinology and Immunology Research Trials Unit (VIRTU), Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wood","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, Specialty of Child and Adolescent Health, Kid\u2019s Research, Sydney Children\u2019s Hospitals Network, The University of Sydney, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[{"name":"School of Medicine and The Kids Research Institute Australia, The University of Western Australia, Perth, Western Austalia, Australia"},{"name":"Departments of Immunology and General Paediatrics, Perth Children\u2019s Hospital, Perth, Western Austalia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Blyth","sequence":"additional","affiliation":[{"name":"PathWest Department of Microbiology, Perth, Western Australia, Australia"},{"name":"School of Medicine and The Kids Research Institute Australia, The University of Western Australia, Perth, Western Austalia, Australia"},{"name":"Departments of Immunology and General Paediatrics, Perth Children\u2019s Hospital, Perth, Western Austalia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Buttery","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, Monash Children\u2019s Hospital, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Clark","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Immunology\/Allergy, Rheumatology, Children\u2019s Health Queensland Hospital and Health Service, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Elliott","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, Specialty of Child and Adolescent Health, Kid\u2019s Research, Sydney Children\u2019s Hospitals Network, The University of Sydney, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R.","family":"Francis","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Royal Darwin Hospital, Darwin, Northern Territory, Australia"},{"name":"Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Macartney","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, Specialty of Child and Adolescent Health, Kid\u2019s Research, Sydney Children\u2019s Hospitals Network, The University of Sydney, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Vaccinology and Immunology Research Trials Unit (VIRTU), Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"},{"name":"Women\u2019s and Children\u2019s Research Centre, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"},{"name":"Robinson Research Institute and School of Medicine, Adelaide University, Adelaide, South Australia, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2445-2952","authenticated-orcid":false,"given":"Bing","family":"Wang","sequence":"additional","affiliation":[{"name":"Vaccinology and Immunology Research Trials Unit (VIRTU), Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"},{"name":"Women\u2019s and Children\u2019s Research Centre, Women\u2019s and Children\u2019s Health Network, Adelaide, South Australia, Australia"},{"name":"Robinson Research Institute and School of Medicine, Adelaide University, Adelaide, South Australia, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on Behalf of the PAEDS investigators and Nurses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"R1-20260811","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","article-title":"Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis.","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"key":"R2-20260811","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1017\/S0950268823000328","article-title":"Epidemiology of invasive meningococcal disease worldwide from 2010\u20132019: a literature review.","volume":"151","author":"Pardo de Santayana","year":"2023","journal-title":"Epidemiol Infect"},{"key":"R3-20260811","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33321\/cdi.2024.48.52","article-title":"Australian meningococcal surveillance programme annual report 2023.","volume":"48","author":"Lahra","year":"2024","journal-title":"Commun Dis Intell"},{"key":"R5-20260811","first-page":"1","article-title":"Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review.","volume":"54","author":"Deghmane","year":"2022","journal-title":"Infect Dis (London, England)"},{"key":"R7-20260811","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis.","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R8-20260811","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s40121-024-01063-5","article-title":"Global epidemiology of meningococcal disease-causing serogroups before and after the COVID-19 pandemic: a narrative review.","volume":"13","author":"Shen","year":"2024","journal-title":"Infect Dis Ther"},{"key":"R9-20260811","doi-asserted-by":"crossref","first-page":"ofae249","DOI":"10.1093\/ofid\/ofae249","article-title":"Genomic surveillance of invasive meningococcal disease during a national MenW outbreak in Australia, 2017\u20132018.","volume":"11","author":"Sotheran","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"R10-20260811","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/21645515.2018.1532248","article-title":"Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies.","volume":"15","author":"Booy","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"R13-20260811","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5694\/mja2.50481","article-title":"First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia.","volume":"212","author":"Marshall","year":"2020","journal-title":"Med J Aust"},{"key":"R14-20260811","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/vaccines13020165","article-title":"Invasive meningococcal disease in the post-COVID world: patterns of disease rebound.","volume":"13","author":"Findlow","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"R18-20260811","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciaf372","article-title":"Long-term protection against invasive meningococcal B disease and gonococcal infection 5 years after implementation of funded childhood and adolescent 4CMenB vaccination program in South Australia: an observational cohort and case-control study.","volume":"81","author":"Wang","year":"2025","journal-title":"Clin Infect Dis"},{"key":"R22-20260811","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.33321\/cdi.2016.40.42","article-title":"Paediatric active enhanced disease surveillance inaugural annual report, 2014.","volume":"40","author":"Zurynski","year":"2016","journal-title":"Commun Dis Intell Q Rep"},{"key":"R23-20260811","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5694\/mja2.52501","article-title":"Towards national paediatric clinical practice guidelines.","volume":"221","author":"Starr","year":"2024","journal-title":"Med J Aust"},{"key":"R26-20260811","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s40121-023-00869-z","article-title":"Range of clinical manifestations caused by invasive meningococcal disease due to serogroup W: a systematic review.","volume":"12","author":"Bertrand-Gerentes","year":"2023","journal-title":"Infect Dis Ther"},{"key":"R27-20260811","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/S0950268819002152","article-title":"Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci.","volume":"148","author":"Stinson","year":"2020","journal-title":"Epidemiol Infect"},{"key":"R28-20260811","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/cid\/ciz578","article-title":"The clinical picture and severity of invasive meningococcal disease serogroup W compared with other serogroups in the Netherlands, 2015\u20132018.","volume":"70","author":"Loenenbach","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R29-20260811","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jinf.2019.11.001","article-title":"Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England.","volume":"80","author":"Campbell","year":"2020","journal-title":"J Infect"},{"key":"R30-20260811","doi-asserted-by":"crossref","first-page":"131","DOI":"10.18773\/austprescr.2019.042","article-title":"Meningococcal vaccines in Australia: a 2019 update.","volume":"42","author":"Sharma","year":"2019","journal-title":"Aust Prescr"},{"key":"R31-20260811","doi-asserted-by":"crossref","DOI":"10.33321\/cdi.2021.45.18","article-title":"Immunisation coverage annual report 2019.","volume":"45","author":"Hull","year":"2021","journal-title":"Commun Dis Intell"},{"key":"R32-20260811","doi-asserted-by":"crossref","DOI":"10.33321\/cdi.2022.46.60","article-title":"Annual immunisation coverage report 2020.","volume":"46","author":"Hull","year":"2022","journal-title":"Commun Dis Intell"},{"key":"R33-20260811","doi-asserted-by":"crossref","first-page":"100640","DOI":"10.1016\/j.lanepe.2023.100640","article-title":"Epidemiology, clinical features and outcome of adults with meningococcal meningitis: a 15-year prospective nationwide cohort study.","volume":"30","author":"van Soest","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"R34-20260811","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/INF.0000000000000043","article-title":"The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children.","volume":"33","author":"Wang","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R35-20260811","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/INF.0000000000003560","article-title":"Sequelae at hospital discharge in 61 children with invasive meningococcal disease, Chile, 2009\u20132019.","volume":"41","author":"Arteta-Acosta","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R36-20260811","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/microorganisms13040705","article-title":"Invasive meningococcal disease in children: outcomes and risk factors for sequelae and fatal cases in Greece.","volume":"13","author":"Poulikakos","year":"2025","journal-title":"Microorganisms"},{"key":"R37-20260811","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijregi.2023.03.013","article-title":"Factors associated with treatment delay and outcome in community acquired bacterial meningitis.","volume":"7","author":"Hovmand","year":"2023","journal-title":"IJID Reg"},{"key":"R38-20260811","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1542\/hpeds.2021-006422","article-title":"Improving time to stat intravenous antibiotic administration: an 8-year quality initiative.","volume":"13","author":"Miller","year":"2022","journal-title":"Hosp Pediatr"},{"key":"R39-20260811","doi-asserted-by":"crossref","first-page":"A1824","DOI":"10.1016\/j.chest.2023.07.1259","article-title":"Improving antibiotic administration time for sepsis rapid response in a metropolitan Veterans Affairs hospital.","volume":"164","author":"Nemeh","year":"2023","journal-title":"Chest"},{"key":"R40-20260811","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12879-022-07129-4","article-title":"Risk of sequelae after invasive meningococcal disease.","volume":"22","author":"Voss","year":"2022","journal-title":"BMC Infect Dis"},{"key":"R42-20260811","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40121-018-0213-2","article-title":"Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers.","volume":"7","author":"Olbrich","year":"2018","journal-title":"Infect Dis Ther"},{"key":"R44-20260811","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1900236","article-title":"Meningococcal B vaccine and meningococcal carriage in adolescents in Australia.","volume":"382","author":"Marshall","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:00:48Z","timestamp":1786420848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005214","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]}}}